Antidepressant-like effect of neurotensin administered in the ventral tegmental area in the forced swimming test
- PMID: 1365637
- DOI: 10.1007/BF02245885
Antidepressant-like effect of neurotensin administered in the ventral tegmental area in the forced swimming test
Abstract
Locomotor activity and behaviour in the forced swimming test were examined in rats which had received neurotensin (0.5-5.0 micrograms) in the ventral tegmental area. Doses of 5 micrograms neurotensin but not lower increased the locomotor activity for at least 2 h. At 0.5 and 1.0 microgram neurotensin significantly increased the time the animals spent in struggling with no changes in general motor activity (swimming). The effect of 1.0 microgram neurotensin on struggling was completely antagonized by 0.5 microgram (-)-sulpiride administered in the posterior nucleus accumbens. The results suggest that activation of the mesolimbic dopamine system through administration of neurotensin in the ventral tegmental area produces antidepressant-like effects. The significance of these findings for a role of endogenous neurotensin in depression remains to be clarified.
Similar articles
-
Effects of neurotensin administered into the ventral tegmental area on prepulse inhibition of startle.Behav Brain Res. 1999 Dec;106(1-2):189-93. doi: 10.1016/s0166-4328(99)00123-0. Behav Brain Res. 1999. PMID: 10595435
-
Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat.Neuroscience. 1983 Mar;8(3):495-505. doi: 10.1016/0306-4522(83)90195-1. Neuroscience. 1983. PMID: 6406930
-
Stimulation of the ventral tegmental area enhances the effect of vasopressin on blood pressure in conscious rats.Br J Pharmacol. 2000 Jan;129(1):29-36. doi: 10.1038/sj.bjp.0702982. Br J Pharmacol. 2000. PMID: 10694199 Free PMC article.
-
SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.Neuroscience. 1994 Apr;59(4):921-9. doi: 10.1016/0306-4522(94)90295-x. Neuroscience. 1994. PMID: 8058127
-
Neuropharmacological profile of non-peptide neurotensin antagonists.Fundam Clin Pharmacol. 1995;9(6):513-21. doi: 10.1111/j.1472-8206.1995.tb00528.x. Fundam Clin Pharmacol. 1995. PMID: 8808171 Review.
Cited by
-
Gender Related Changes in Gene Expression Induced by Valproic Acid in A Mouse Model of Autism and the Correction by S-adenosyl Methionine. Does It Explain the Gender Differences in Autistic Like Behavior?Int J Mol Sci. 2019 Oct 24;20(21):5278. doi: 10.3390/ijms20215278. Int J Mol Sci. 2019. PMID: 31652960 Free PMC article.
-
Neurotensin and Neurotensin Receptors in Stress-related Disorders: Pathophysiology & Novel Drug Targets.Curr Neuropharmacol. 2024;22(5):916-934. doi: 10.2174/1570159X21666230803101629. Curr Neuropharmacol. 2024. PMID: 37534788 Free PMC article. Review.
-
To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance.Front Syst Neurosci. 2015 Feb 18;9:9. doi: 10.3389/fnsys.2015.00009. eCollection 2015. Front Syst Neurosci. 2015. PMID: 25741247 Free PMC article. Review.
-
Depression and antidepressants: molecular and cellular aspects.Cell Mol Life Sci. 2009 Sep;66(18):2985-3008. doi: 10.1007/s00018-009-0055-x. Epub 2009 Jun 12. Cell Mol Life Sci. 2009. PMID: 19521663 Free PMC article. Review.
-
Altered sleep and affect in the neurotensin receptor 1 knockout mouse.Sleep. 2012 Jul 1;35(7):949-56. doi: 10.5665/sleep.1958. Sleep. 2012. PMID: 22754041 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical